Business Context and Reporting Period
This Form 8-K, filed on March 23, 2011, by SANUWAVE Health, Inc., discloses a material weakness in internal controls and a subsequent restatement of financial statements for the fiscal year ended December 31, 2008. The filing addresses errors in the accounting for stock-based compensation.
Key Financial Metrics and Restatement Impact
The filing details a non-cash adjustment of $687,309 related to stock options granted in April 2008. The error stemmed from using a four-year straight-line vesting schedule instead of accounting for 50% of the options being vested at the date of grant. The filing provides the following restated figures for the year ended December 31, 2008:
- Revenues: $1,045,858 (No change)
- Operating Expenses: Increased from $12,060,527 to $12,747,836 due to a $687,309 increase in General and Administrative expenses.
- Net Loss: Increased from $(9,408,918) to $(10,096,227).
- Net Loss Per Share (Basic/Diluted): Increased from $(0.85) to $(0.92).
- Cash Flow: No impact on net cash used by operating activities, which remained at $7,009,402.
- Balance Sheet: Additional paid-in capital increased by $687,309, and retained deficit increased by $687,309. Total assets and total liabilities remained unchanged.
Material Changes Versus Prior Period
The primary material change is the restatement of the 2008 financial statements. The originally reported 2008 net loss was understated by $687,309. Consequently, the beginning balances for the 2009 fiscal year for additional paid-in capital and retained deficit were adjusted upward and downward, respectively, by the same amount. There was no impact on the 2009 operating results or cash flows, only the opening equity balances.
Management Commentary, Risks, and Outlook
Management identified the error as a result of a material weakness in internal control over financial reporting, specifically regarding the accounting for stock compensation expense. The company is actively developing a remediation plan, which includes redesigning procedures to better identify, capture, review, and record contractual terms in equity arrangements. The company intends to file its 2010 Annual Report on Form 10-K, incorporating these adjustments, no later than March 31, 2011. The filing notes that all adjustments are non-cash in nature.
Investor Verification Checklist
- Verify the upcoming Form 10-K filing for the fiscal year ended December 31, 2010, to confirm the full integration of the 2008 restatement.
- Review the company's remediation plan for the identified material weakness in internal controls over stock compensation accounting.
- Confirm that the restated 2008 figures are reflected in comparative periods within future financial reports.
- Monitor for any further disclosures regarding the audit process or additional adjustments to prior periods.